# Passage BIO, Inc.: Form 8-K, filed Mar 10, 2026

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: 8-K
- Filed: 2026-03-10
- Accepted by EDGAR: Mar 10, 2026, 07:15 ET
- Period: 2026-03-04
- Accession: 0001104659-26-025550
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000110465926025550/tm268398d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000110465926025550/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000110465926025550/tm268398d1_8k.htm

Filed Mar 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-025550. Last ingested by Listed: Nov 6, 2026, 11:01 ET. No prices; not investment advice.